Hypermarcas (OTCMKTS:HYPMY) Sees Unusually-High Trading Volume – Time to Buy?

Hypermarcas (OTCMKTS:HYPMY) saw unusually-strong trading volume on Friday . Approximately 28,871 shares traded hands during trading, an increase of 25% from the previous session’s volume of 23,057 shares.The stock last traded at $4.61 and had previously closed at $4.63.

Analyst Ratings Changes

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy”.

Hypermarcas Stock Down 0.3%

The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. The stock has a market cap of $3.25 billion, a price-to-earnings ratio of 9.62 and a beta of 0.73. The business’s fifty day moving average is $4.46 and its two-hundred day moving average is $4.52.

Hypermarcas (OTCMKTS:HYPMY) last released its earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. The company had revenue of $383.13 million for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. Equities analysts forecast that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.